Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test may let some stomach cancer patients skip harsh chemo after surgery
Knowledge-focused Not yet recruitingThis study tests whether a personalized blood test (Signatera) can identify stomach cancer patients who have no cancer DNA left after surgery, allowing them to safely receive a milder immunotherapy (durvalumab) instead of standard chemotherapy. About 1,000 patients will be follow…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:55 UTC
-
Blood test may spare some women from radiation after endometrial cancer surgery
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tumor DNA can help decide if women with early-stage endometrial cancer need radiation after surgery. About 1,010 women will be followed for two years. Those with a negative blood test may safely skip radiation, while others re…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC